Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic Transcranial Magnetic Stimulation (TMS)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-035 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic ShoesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-020 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, and AntiepilepticsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-029 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tezepelumab-ekko (Tezspire)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-144 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teprotumumab (Tepezza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-115 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teplizumab-mzwv (Tzield)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-157 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Telisotuzumab vedotin-tllv (Emrelis)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-040 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Telehealth ServicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-036 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Teclistamab-cqyv (Tecvayli)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-156 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tebentafusp-tebn (Kimmtrak)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-143 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tarlatamab-dlle (Imdelltra for intravenous usePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-176 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Talquetamab-tgvs (Talvey)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-166 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Tafasitamab-cxix (Monjuvi)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-138 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sutimlimab-jome (Enjaymo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-145 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Treatments of Athletic PubalgiaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-093 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Treatment of NailsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-036 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical Procedures of the Eyelid and BrowPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-047 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-004Q-C5B9D73772 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Surgery for GynecomastiaPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-110 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA10-008 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Steroid-Eluting Sinus Stents and ImplantsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-107F-2041F675E5 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Stem-Cell Therapy/Platelet-Rich Plasma for Orthopedic Applications and Platelet-Rich Plasma/Platelet-Derived Growth Factor for Wound Healing and Other Miscellaneous Non-Orthopedic ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-008 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | STAT Laboratory Tests Performed in the Outpatient Hospital Setting for Health Maintenance Organization (HMO) and Point-of-Service (POS) ProductsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-021 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Standing FramesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-055 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Spinal OrthosesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-030F-11A2FC388D | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Spinal Decompression with Interspinous and Interlaminar DevicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-048 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Spesolimab-sbzo (Spevigo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-155 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Speech TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA10-007 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Speech and Non-Speech Generating DevicesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-003 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Solid Organ Transplantation and Procurement Cost of Organs and TissuesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-033 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sleep Disorder Testing and Positive Airway Pressure Therapy Services and SuppliesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-058M-ADE6C85689 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Skilled Nursing Facility (SNF): Skilled and Subacute Levels of CarePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA02-004 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Site of Care for Elective Procedures [Hospital Outpatient Setting to Ambulatory Surgical Center (ASC)]PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA12-005 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Services Paid Above Capitation for Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Primary Care ProvidersPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-033 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Serodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus IBD sgi Diagnostic TestPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-013 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sentinel Lymph Node Biopsy and MappingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-068 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-071 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Secukinumab (Cosentyx) for Intravenous UsePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-174 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sebelipase alfa (Kanuma)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-078 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Seat Lift MechanismsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-011 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA09-013 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Scar RevisionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-078 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-004 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of IncontinencePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-028 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Sacituzumab govitecan-hziy (Trodelvy)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-118 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Rozanolixizumab-noli (Rystiggo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-164 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Routine Foot Care for Certain Medical ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-009 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Routine Costs of Clinical Trials and Coverage of Investigational Devices A and BPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-004 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Rituximab (Rituxan) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-022 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Risankizumab-rzaa (Skyrizi) for intravenous usePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-153 | New policy |
|---|